Our Network of Consultants

My area of study is the intersection of clinical neuroscience, translational pharmacology, and computational biomarker discovery. I am a PhD candidate investigating how glymphatic and meningeal–lymphatic pathways relate to neuroinflammation in humans. I focus on immune-cell phenotyping and cell-free markers that may index inflammatory activity and neurodegenerative trajectories. Alongside sampling development, I contribute to assay and workflow optimisation for mass-spectrometry-ready proteomics, with an emphasis on automation, quality control, and reproducibility.

My pharmacology and drug-safety foundation was built through an MRes in Biological Science and Translational Medicine. I examined dose- and time-dependent paracetamol-induced kidney injury in renal cell models, differentiating apoptotic and necrotic mechanisms and linking experimental readouts to clinically relevant nephrotoxicity questions. I completed a systematic review on cilastatin as a renoprotective strategy and critically evaluated in vitro acute kidney injury models for translational validity. I also gained ward-level exposure as a Clinical Research Associate in nephrology, aligning laboratory findings with real-world clinical pathways and multidisciplinary decision-making.

From an industry and communications perspective, I have experience in medical affairs-adjacent work, including market analysis to support launch planning in an ophthalmic pharmaceutical company and the development of compliant training materials with medical teams. I have delivered conference and hospital presentations, tailoring complex findings to both clinical and public audiences, and I have completed structured projects on European compliance frameworks, which underpins my approach to regulatorily aware medical writing.

Computationally, I build end-to-end machine-learning workflows in Python and R for noisy, high-dimensional datasets, particularly proteomics and multimodal clinical data. My toolkit spans supervised learning, unsupervised clustering, and dimensionality reduction.

Overall, my expertise is translating complex biomedical and quantitative evidence into actionable deliverables, supported by an MBA in Clinical Leadership and a strong biochemistry foundation, including earlier research on TEX12 expression in somatic and cancer models.

With over 25 years of leadership in the Life Sciences and Diagnostics market, I have built a proven track record of blending entrepreneurial vision with strategic business management expertise. Drawing from a wealth of experience across Business Development, R&D, Marketing, Sales, and Manufacturing, I have developed a deep technical foundation that drives a passion for revenue growth, market share expansion, and profit performance enhancement.

My leadership is defined by a commitment to innovation and a solution-oriented mindset, consistently helping businesses navigate complex challenges while fostering sustainable, high-impact partnerships across global markets.

Key Strengths:
• Building and scaling international distribution and sales channels
• Motivating and guiding teams to accelerate revenue growth
• Driving success in OEM and B2B sales strategies
• Leading contract negotiations, technology transactions, and licensing agreements
• Spearheading global business development across EMEA, APAC, LATAM, and Africa

By leveraging my expertise, global connections, and industry insights, companies can optimize their distribution networks, ensuring measurable results and maximizing revenue. With a focus on fine-tuning distribution strategies, together we can deliver sustainable growth across key regions.

As a Professor of Chemistry at King's College London and Group Leader at the Francis Crick Institute, following nine years at Oxford University where I was also a Royal Society University Research Fellow, I bring over 20 years of experience at the intersection of biophysics, chemistry, and nanotechnology. My research has pioneered novel approaches in membrane biophysics and single-molecule detection, leading to fundamental breakthroughs in nanopore sensing technology. I have developed four patented innovations in this field, with three successfully licensed to industry partners, including methods that enable five-order magnitude improvements in DNA sequencing throughput.

My expertise spans single-molecule microscopy, membrane protein biophysics, microfluidics, and the development of artificial cell membrane systems. I've developed particular specialization in membrane protein function, interferometric scattering microscopy, and optical single-channel recording, contributing to over 70 peer-reviewed publications. This work has been recognized with multiple honors including election as a Fellow of the Royal Society of Chemistry and the RSC Norman Heatley Award.

As a regular reviewer for leading journals including Science and Nature, I maintain active engagement with cutting-edge developments across biophysics and nanotechnology. I've held appointments at Oxford, Stanford, and Cambridge universities, building a broad international network in academia and industry. My experience includes serving as an invited nominator for the Chemistry Nobel Committee, consulting for biotechnology companies, and maintaining successful research collaborations with leading biotech partners.

My technical knowledge spans patent disputes, particularly those involving biophysics and nanopore sensing technologies, complemented by extensive experience in technology commercialization and independent technical review.

A distinguished life science professional with over 33 years of extensive experience in research, leadership, and innovation, adeptly navigating the complexities of the biotech and life science sectors as the founder of LMF Biosciences and currently holding key executive positions at Biosensis Pty. Limited, Symansis Limited, as well as previous roles at EMD-Millipore and Chemicon. I have demonstrated exceptional prowess in driving organizational growth, developing strategic partnerships, and leading high-impact projects across various scientific disciplines from Cell Biology and Neuroscience to Molecular Biology, Cancer, and Metabolic Disease.
My career is highlighted by significant contributions to technical and customer service excellence, playing a pivotal role in the success of major companies like Millipore and Chemicon International. My expertise encompasses a wide range of technical skills, from the basics of immunohistochemistry and western blot, DNA/RNA manipulation, molecular cloning, and PCR to a comprehensive knowledge of cell culture techniques and protein analysis, making me a respected educator and trainer in the life science community.

With a solid track record of leading multi-person teams and directing technical service organizations, I have consistently delivered world-class service, support, and scientific assistance crucial to business success in the life science reagents sector. My strategic vision and innovative approach have been instrumental in product development, customer engagement, and identifying future growth areas, enabling companies to better anticipate and meet the diverse needs of their customers.

Beyond technical expertise, my leadership roles have showcased my ability to effectively manage and expand life science markets, achieving and surpassing sales targets while fostering sustainable growth. My entrepreneurial spirit, scientific understanding, and business insight make me an invaluable asset to any organization aiming to excel in the competitive biotech and life science research reagents landscape.

In summary, I offer a unique blend of scientific excellence, strategic business management, and visionary leadership, making me an ideal candidate for roles that demand depth of knowledge, innovative thinking, and a proven track record of success in the life sciences sector.

With a distinguished background, which includes a PhD and an eMBA, I seamlessly integrate scientific and technical expertise with a profound understanding of global business strategy in chemistry for the biology, assay development and detection methods.

Innovator with extensive experience and a proven track record of developing successful corporate strategies that increase revenues in the Life Sciences industry. Creative visionary and change agent who identifies growth markets, business drivers and builds collaborative global and cross-functional relationships. Recognized for combining transformational business strategies with supporting business cases, operating plans, budgets, and programs.
EXPERTISE
Strategic Planning | M&A | Financial Analysis | Partnerships and IVs | Market Assessments | Negotiation | Deal Structuring | Due Diligence
APPLICATIONS
Flow cytometry, antibodies, reagents, dyes, instruments ( sorters and analyzers)

Having worked as a product and commercial manager for 18 years within the life science industry, my focus was always to identify cutting edge technology, applications and novel scientific companies, working with them to present their products to the wider research and IVD markets. With a skillset focused on bringing novel technologies to new markets and working to build diverse, integrated portfolios for platforms, my experience, combined with my scientific knowledge, placed me well to work within Mergers & Acquisitions on both buy side and sell side transactions along with strategic pieces.
Specialities: Biotech & Life science Consultancy, specialising in Business Development, strategy and M&A assistance.
Specialises in understanding how the scientific capabilities of companies can be presented to the life science customer base or utilised to build upon strengths of platforms for inorganic expansion.